Safety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCLC Pre-treated With Immunotherapy

Name: Safety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCLC Pre-treated With Immunotherapy
License: Public Domain

Baohui Han

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

extensive-stage small-cell lung cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 628538
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.